|
Applebaum, J; Reynolds, S; Knispel, J et al. (1998) Identification of melanoma antigens that are immunogenic in humans and expressed in vivo. J Natl Cancer Inst 90:146-9
|
|
Bystryn, J C (1998) Vaccines for melanoma. Design strategies and clinical results. Dermatol Clin 16:269-75
|
|
Reynolds, S R; Celis, E; Sette, A et al. (1998) HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients. J Immunol 161:6970-6
|
|
Reynolds, S R; Oratz, R; Shapiro, R L et al. (1997) Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer 72:972-6
|
|
Bystryn, J C; Shapiro, R L; Harris, M et al. (1996) Use of vaccines in treatment of malignant melanoma. Clin Dermatol 14:337-41
|
|
Schultz, N; Oratz, R; Chen, D et al. (1995) Effect of DETOX as an adjuvant for melanoma vaccine. Vaccine 13:503-8
|
|
Cui, J; Chen, D; Misfeldt, M L et al. (1995) Antimelanoma antibodies in swine with spontaneously regressing melanoma. Pigment Cell Res 8:60-3
|
